Appili Therapeutics Inc. APLI.TO
Health Care · Pharmaceuticals, Biotechnology & Life Sciences · TSX · Canada · appilitherapeutics.com
Appili Therapeutics Inc. is a Canadian biopharmaceutical company focused on developing anti-infective drugs and medical countermeasures for infectious diseases. The company's pipeline includes an FDA-approved metronidazole suspension, a biodefense vaccine candidate, and a topical antiparasitic treatment.
Key ratios
FreeCashFlowOnSale TTM -0.05
FreeCashFlowOnSale 2025 8.63
FreeCashFlowOnSale 2024 -3.01
FreeCashFlowOnSale 2023 -30.22
ReturnOnAssets TTM -2.92
ReturnOnAssets 2025 -2.79
ReturnOnAssets 2024 -2.18
ReturnOnAssets 2023 -0.87
Recent news
Appili Therapeutics Reports Fiscal Year 2026 Financial and Operational Results
2026-06-26 · GlobeNewswire